"Breakthrough: Scientists Develop Synthetic Antibiotic to Combat Drug-Resistant Superbugs"

Researchers at the University of Illinois Chicago and Harvard University have developed a new antibiotic, cresomycin, that effectively suppresses drug-resistant bacteria by evading their defenses. The antibiotic, described in Science, targets the ribosome and is designed to overcome common bacterial resistance mechanisms. In animal experiments, cresomycin protected against infections with multidrug-resistant strains of common disease-causing bacteria. The next step is to assess its effectiveness and safety in humans, highlighting the critical role of structural biology in designing the next generation of antibiotics.